NEVVI Medicare utilization intelligence

← back

SESHADRI, VIDYAM.D. NPI 1184843369 Clinician

Hematology-Oncology · BOWLING GREEN, KY

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 33 years since medical school (class of 1993, self-reported to CMS)
Location BOWLING GREEN, KY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 87 codes billed · 211,031 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
GRAVES GILBERT CLINIC PLLC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2019-08

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9271 Injection, pembrolizumab, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J0897 Injection, denosumab, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1453 Injection, fosaprepitant, 1 mg
A9575 Injection, gadoterate meglumine, 0.1 ml
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J1437 Injection, ferric derisomaltose, 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
96372 Injection of drug or substance under skin or into muscle
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J2469 Injection, palonosetron hcl, 25 mcg
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
82607 Cyanocobalamin (vitamin b-12) level
82784 Gammaglobulin (immune system protein) measurement
84443 Blood test, thyroid stimulating hormone (tsh)
83615 Lactate dehydrogenase (enzyme) level
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
71260 Ct scan of chest with contrast
74177 Ct scan of abdomen and pelvis with contrast
J9045 Injection, carboplatin, 50 mg
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
82533 Cortisol (hormone) measurement, total
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
J3490 Unclassified drugs
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
J7030 Infusion, normal saline solution , 1000 cc
84153 Psa (prostate specific antigen) measurement, total
96523 Irrigation of implanted venous access drug delivery device
96417 Administration of additional new drug or substance into vein, 1 hour or less
81001 Manual urinalysis test with examination using microscope, automated
96361 Infusion into a vein for hydration, each additional hour
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
82378 Carcinoembryonic antigen (cea) protein level
83735 Magnesium level
82306 Vitamin d-3 level
96360 Infusion into a vein for hydration, 31-60 minutes
71046 X-ray of chest, 2 views
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
82565 Blood creatinine level
77080 Dxa bone density measurement of hip, pelvis, spine
84550 Uric acid level, blood
85652 Red blood cell sedimentation rate, to detect inflammation, automated
84100 Phosphate level
96411 Administration of additional new drug or substance into vein using push technique
84520 Urea nitrogen level to assess kidney function, quantitative
99195 Drawing of blood for a medical problem
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
77063 Screening 3d breast mammography
77067 Screening mammography
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
96374 Injection of drug or substance into vein
36591 Collection of blood sample from implanted device
70491 Ct scan of soft tissue of neck with contrast
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
87086 Bacterial colony count, urine
70553 Mri scan of brain before and after contrast
71250 Ct scan of chest without contrast
74176 Ct scan of abdomen and pelvis without contrast
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus
78306 Nuclear medicine study of bone and/or joint whole body
80061 Blood test, lipids (cholesterol and triglycerides)
93971 Ultrasound study of one arm or leg veins with compression and maneuvers
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
36415 Insertion of needle into vein for collection of blood sample
76642 Limited ultrasound scan of 1 breast
84439 Thyroxine (thyroid chemical), free
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.